Search Results - "Imai, Shigemi"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    A HER2/NEU-derived peptide, a K(d)-restricted murine tumor rejection antigen, induces HER2-specific HLA-A2402-restricted CD8(+) cytotoxic T lymphocytes by Ikuta, Y, Okugawa, T, Furugen, R, Nagata, Y, Takahashi, Y, Wang, L, Ikeda, H, Watanabe, M, Imai, S, Shiku, H

    Published in International journal of cancer (15-08-2000)
    “…We have identified an H-2K(d)-binding peptide, HER2p780 (PYVSRLLGI), derived from murine HER2/neu (HER2), that can induce HER2-specific murine cytotoxic T…”
    Get full text
    Journal Article
  2. 2

    A novel human HER2-derived peptide homologous to the mouse K(d)-restricted tumor rejection antigen can induce HLA-A24-restricted cytotoxic T lymphocytes in ovarian cancer patients and healthy individuals by Okugawa, T, Ikuta, Y, Takahashi, Y, Obata, H, Tanida, K, Watanabe, M, Imai, S, Furugen, R, Nagata, Y, Toyoda, N, Shiku, H

    Published in European journal of immunology (01-11-2000)
    “…A mouse HER2-derived peptide, HER2p63 (A) (TYLPANASL), can induce K(d)-restricted mouse cytotoxic T lymphocytes (CTL) and also function as a tumor rejection…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6

    Neonatal alloimmune thrombocytopenic purpura associated with sensitization against the platelet-specific antigen Yuk(a) by Matsuda, T, Yonaha, H, Azuma, E, Sakurai, M, Imai, S

    Published in American journal of hematology (01-11-1990)
    “…We report a Japanese newborn who developed alloimmune thrombocytopenia by the antibodies to the newly discovered platelet antigen Yuk(a). The infant recovered…”
    Get more information
    Journal Article